Page last updated: 2024-10-26

donepezil and Autoimmune Diabetes

donepezil has been researched along with Autoimmune Diabetes in 1 studies

Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Klinge, MW1
Borghammer, P1
Lund, S1
Fedorova, T1
Knudsen, K1
Haase, AM1
Christiansen, JJ1
Krogh, K1

Other Studies

1 other study available for donepezil and Autoimmune Diabetes

ArticleYear
Enteric cholinergic neuropathy in patients with diabetes: Non-invasive assessment with positron emission tomography.
    Neurogastroenterology and motility, 2020, Volume: 32, Issue:1

    Topics: Adult; Carbon Radioisotopes; Cholinergic Neurons; Diabetes Mellitus, Type 1; Donepezil; Female; Huma

2020